Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q1 2019 · 10-Q
Revenue$0.00$0.00— vs Q1 2018 Net Income-$3.06M-$3.06MN/M vs Q1 2018 EPS Diluted-$0.02-$0.02N/M vs Q1 2018 Operating Income-$967,852N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 13, 2019 · 43 d after period end